Clinical Trials

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittes, J.
Right arrow Articles by Yusuf, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittes, J.
Right arrow Articles by Yusuf, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Trials, Vol. 4, No. 3, 218-234 (2007)
DOI: 10.1177/1740774507079439
© 2007 The Society for Clinical Trials

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board

Janet Wittes

Statistics Collaborative, Washington DC, USA, janet{at}statcollab.com

Elizabeth Barrett-Connor

University of California, San Diego, California, USA

Eugene Braunwald

Harvard Medical School, Boston, Massachusetts, USA

Margaret Chesney

National Center for Complementary and Alternative Medicine, Bethesda, Maryland, USA

Harvey Jay Cohen

Duke University Medical School, Durham, North Carolina, USA

David DeMets

University of Wisconsin, Madison, Wisconsin, USA

Leo Dunn

Virginia Commonwealth University, Richmond, Virginia, USA

Johanna Dwyer

National Institutes of Health, Bethesda, Maryland, USA

Robert P. Heaney

Creighton University, Omaha, Nebraska, USA

Victor Vogel

University of Pittsburgh, Pittsburgh, Pennsylvania, USA

LeRoy Walters

Georgetown University, Washington DC, USA

Salim Yusuf

McMaster University, Hamilton, Ontario, Canada

Data Safety Monitoring Committees (DSMB) for large, long-term randomized trials of agents in common use face challenging problems especially when the emerging data indicate unanticipated effects. The DSMB for the Women's Health Initiative Clinical Trials, on observing early indication of a surprising adverse cardiovascular effect of post-menopausal hormones, spent several years deliberating what recommendations it should make. This paper describes the dilemmas faced by the DSMB and the considerations it made over the course of its existence. The paper concludes with some recommendations for other DSMBs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?